Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Ernexa Therapeutics Inc. - Warrants (04/02/2030)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ernexa Therapeutics Inc. - Warrants (04/02/2030) 52 week high is $0.12 as of February 25, 2026.
What is the 52-week low for Ernexa Therapeutics Inc. - Warrants (04/02/2030)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ernexa Therapeutics Inc. - Warrants (04/02/2030) 52 week low is $0.0499 as of February 25, 2026.
What is Ernexa Therapeutics Inc. - Warrants (04/02/2030) stock price today?
Ernexa Therapeutics Inc. - Warrants (04/02/2030) stock price today is $0.07.
What was Ernexa Therapeutics Inc. - Warrants (04/02/2030) stock price yesterday?
Ernexa Therapeutics Inc. - Warrants (04/02/2030) stock price yesterday was $0.061.
What is the 50-day moving average of Ernexa Therapeutics Inc. - Warrants (04/02/2030)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ernexa Therapeutics Inc. - Warrants (04/02/2030) 50-day moving average is $0.0694.